Sanofi Plans Final Tests as Regeneron Drug Cuts Eczema Symptoms

Sanofi and Regeneron Pharmaceuticals Inc. said they plan to test their experimental eczema treatment in large late-stage studies after a smaller trial reduced symptoms of the scaly, itching disease.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.